Mezzion PharmaLtd Balance Sheet Health
Financial Health criteria checks 5/6
Mezzion PharmaLtd has a total shareholder equity of ₩61.4B and total debt of ₩499.6M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ₩92.1B and ₩30.7B respectively.
Key information
0.8%
Debt to equity ratio
₩499.58m
Debt
| Interest coverage ratio | n/a |
| Cash | ₩58.25b |
| Equity | ₩61.44b |
| Total liabilities | ₩30.70b |
| Total assets | ₩92.15b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A140410's short term assets (₩74.2B) exceed its short term liabilities (₩29.6B).
Long Term Liabilities: A140410's short term assets (₩74.2B) exceed its long term liabilities (₩1.1B).
Debt to Equity History and Analysis
Debt Level: A140410 has more cash than its total debt.
Reducing Debt: A140410's debt to equity ratio has increased from 0.4% to 0.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A140410 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A140410 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 2.3% each year